Related by context. All words. (Click for frequent words.) 77 Thalomid ® 68 commercialize CorMedix drug 67 Prednisporin 66 Miikana 66 Zemiva TM Trofex TM 65 XL# anticancer compounds 65 contingent guaranties 64 Generx TM 64 proprietary Isolagen Process 64 Zemiva TM 64 sNDAs 64 Kosan dependence 64 novel L DOS# 63 candidate REP# 63 IV APAP 63 biomimetics non 63 Alnylam dependence 63 RAPTIVA R 63 XP# XP# 63 Amgen Kyowa Hakko Kirin 63 Solazed 63 commercialized DURECT 63 BioSante licensees 63 Empatic ™ 63 Trofex ™ 62 EVIZON TM squalamine lactate 62 please visit www.medicinova.com 62 thrombin component 62 RAPTIVA r 62 Immtech clinical trials 62 RH1 targeted chemotherapeutic agent 62 Solazed TM 62 Canvaxin TM 62 TranSwitch indebtedness 62 successfully commercialize Iluvien 62 HEPLISAV ™ 62 include GALNS N 62 INTEGRILIN R eptifibatide Injection 62 OraTest R 62 ionotropic glutamate receptor antagonists 61 Exelixis compounds 61 TRIOLEX ™ 61 Asentar TM 61 Naglazyme R 61 DIFICID ™ 61 5 lipoxygenase inhibitor 61 Rosetta dependence 61 Acetavance TM 61 Acetavance TM intravenous acetaminophen 61 AzaSite TM 61 developing ostarine selective 61 muscarinic receptor agonist 61 ESTRASORB ® 61 ZYFLO CR 61 LEP ETU 61 Azedra TM Onalta TM 61 Telik logo TELINTRA 61 ix Immtech ability 61 TOCOSOL Camptothecin 61 proprietary intravenous formulation 61 synthetic anti infective 61 TRIOLEX HE# APOPTONE HE# 61 clinical trials dacetuzumab SGN 61 fusion enhancers 61 ENABLE Phase 2 61 signal averaging electrocardiography 61 acetylgalactosamine 6 61 novel emulsion formulation 61 AcryMed Incorporated 61 BioGlue ® 61 please visit http:/www.sunesis.com 60 sumatriptan DosePro 60 INTEGRILIN ® 60 IMPDH inhibitor 60 MOVIPREP R 60 Rexahn licensees 60 commercialize ZYFLO CR 60 Synavive ™ 60 dacetuzumab collaboration 60 R MSCRAMM 60 Bioenvision dependence 60 STRIANT ® 60 PRAVACHOL R 60 proprietary Capillary Aerosolization Technology 60 Auxilium anticipates 60 SinuNase ™ 60 Severe hypersensitivity reactions 60 MAb therapy 60 regarding Heska 60 Zemiva ™ 60 ® bortezomib 60 dihydrochloride Phase 3 60 torsemide ER 60 HepeX B 60 developing ACAPODENE 60 tivozanib AV 60 inflammatory autoimmune diseases 60 please visit www.middlebrookpharma.com 60 please visit http:/www.atherogenics.com 60 THALOMID 59 treats acute lymphoblastic 59 Evoltra ® 59 pharmacogenomic translational research 59 Bioaccelerate compounds under 59 R sorafenib tablets 59 SILENOR 59 topical antifungal product 59 LX# LX# LX# 59 SILENOR ™ 59 CoTherix logo 59 Trofex TM 59 expenses associated therewith 59 XL# XL# XL# XL# 59 PANVAC VF 59 Cardium Therapeutics TM 59 xi unanticipated 59 Nabi HB 59 Aradigm Logo 59 cMET inhibitor 59 PREOS R 59 OREXIGEN 59 please visit http:/www.vandapharma.com 59 Allovectin 7 r 59 Eligard ® 59 OMNARIS Nasal Spray 59 NUEDEXTA ™ 59 AzaSite Plus 59 Heska reliance 59 Idera Pharmaceuticals develops 59 Dyax logo 59 sapacitabine CYC# 59 Azactam 59 PLAVIX ® 59 visit www.targanta.com 59 Inc. NASDAQ ZLCS 59 chemotherapy induced neutropenia 59 oncolytic virus therapies 59 PGP Acquisition 59 Panflu TM 59 PROCHIEVE ® 59 candidates Azedra TM 59 androgen receptor modulator 59 Exelixis logo 59 dextromethorphan quinidine 59 Maxy G# 59 XOMA 3AB 59 COLAZAL R 59 CCR2 antagonists 59 muscarinic receptor agonists 59 Alzheimer disease cognitive dysfunction 59 non nucleoside HCV 59 Xcytrin R 59 Hectorol R 59 hypoxia activated prodrug 59 Eligard R 59 Oxandrin R 59 Oxandrin 59 Submits Response 59 please visit www.lexpharma.com 59 Pruvel ™ prulifloxacin 59 NeoLipid drug 59 Cintredekin Besudotox 59 Anturol ® 58 Lovaza TM 58 Intermezzo ® zolpidem tartrate 58 Other ImmunoGen collaborative 58 TRISENOX R 58 Puricase PEG uricase 58 GVAX ® 58 TOCOSOL Paclitaxel 58 Oxandrin ® 58 sores onychomycosis nail 58 LOPROX R 58 Phase III LibiGel 58 Azedra ™ 58 evaluating bafetinib 58 XAGRID 58 risksassociated 58 Submits NDA 58 lintuzumab SGN 58 Submits Biologics License Application 58 consummating acquisitions 58 assimilating acquired 58 CRINONE R 58 CIP TRAMADOL ER 58 orBec R oral beclomethasone 58 pentadentate logo R 58 HuMax TAC 58 JUVISTA 58 AMWO 58 MGCD# MGCD# [001] 58 adopting SFAS #R 58 Crofelemer budesonide foam 58 TriPath Oncology 58 CEFF financings subject 58 DOS# 58 Advicor R 58 IL# PE 58 APTIMA HPV assay 58 include Phenoptin TM 58 Kerastick 58 elotuzumab 58 CytRx oncology 58 TP# CETi 1 58 EHT AGN 58 technological innovations adversely affecting 58 Asentar ™ 58 Chaim Lebovits President 58 SOLODYN R 58 Cephalon GlaxoSmithKline Organon 58 ADSI reliance 58 NeutroSpec TM 58 Pruvel 58 Inc. www.micromet inc.com 58 molecular chaperone regulation 58 cosmetic cosmeceutical products 58 orBec ® oral beclomethasone 58 vosaroxin 58 Oral NKTR 58 ability tosuccessfully 58 vii Cubist ability 58 ABELCET 58 commercialize BiDil 58 Initiates Enrollment 58 Healive TM 58 ZEFFIX 58 PrevOnco 58 Tß4 58 Rotarix ® 58 cadence regulatory approvals 58 Adenoscan R 58 MOSAID litigation 58 valopicitabine NM# 57 Zenvia ™ 57 Hematide ™ peginesatide 57 indications Cytokinetics 57 agonistic human 57 STRIANT R 57 valtorcitabine 57 Exalgo TM 57 tumor activated prodrug 57 ALN PCS 57 candidate CRLX# 57 intranasal insulin product 57 include ClindaReach TM 57 Xoma Ltd 57 Nventa proprietary CoVal 57 Exalgo ™ 57 Duromist ™ 57 concerning CombinatoRx 57 Optiquel ™ 57 Omigard TM 57 trivalent seasonal influenza 57 treat chronic sinusitis 57 drilling recompletions 57 Vaxfectin R 57 mergers dispositions 57 include PLX IBD 57 Neo Kidney Augment 57 Eloxatin ® 57 DCVax R Prostate 57 Orapred ODT 57 KRYSTEXXA TM pegloticase 57 OvaRex ® MAb 57 ENZON 57 ZADAXIN ® 57 CCR5 inhibitors entry 57 TELINTRA 57 PEG PAL 57 VANTAS 57 SinuNase TM novel 57 successfully commercialize Silenor 57 Metabasis stockholders 57 cinacalcet HCl 57 FOLFOX6 chemotherapy regimen 57 generic oral contraceptive 57 Sular ® 57 oral picoplatin 57 MSCRAMM ® 57 Seabridge cautions 57 alemtuzumab MS 57 fexofenadine hydrochloride 57 Trubion proprietary 57 R bortezomib 57 Androxal TM 57 kidney urologic 57 statementsregarding 57 Sulonex TM 57 Acapodene R 57 REMOXY POSIDUR ELADUR 57 progesterone gel 57 Vivelle Dot ® 57 Panzem R NCD 57 Verint Systems Inc 57 Triapine R 57 Shire plc Attention Deficit 57 nalbuphine ER 57 ESTRASORB 57 BEMA Granisetron 57 Aloxi injection 57 AudioCodes filings 57 M# rationally 57 AeroLEF R 57 e mail lifestyle@readingeagle.com 57 commercialize Qutenza 57 Zolpimist ™ 57 CholeraGarde R Peru 57 pulls Darvon painkiller 57 diabetes irritable bowel 57 Amigal TM 57 sulfonylurea glimepiride 57 visit www.sciclone.com 57 manufacture PolyHeme 57 Nycomed GmbH 57 Dyax phage display 57 ALLEGRA ® 57 LE SN# 57 Advicor 57 InterfeRx 57 LUCENTIS r 57 CLIRS trial 57 generic oral contraceptives 57 diagnostic radiopharmaceutical 57 EMPOWER pivotal trial 57 Cytogen marketed 57 Amgen Bayer Schering 57 OvaRex R 57 serious cardiovascular thrombotic 57 Empatic TM 57 sumatriptan succinate 57 Nanobody R 57 AN# novel 57 incur unanticipated 57 visit www.noven.com 57 TKM ApoB 57 Linjeta TM 57 technology visit http:/www.genmab.com 57 pipeline GlycoPEG GCSF 57 BioGlue R 57 AAG geldanamycin analog 57 AzaSite Xtra 57 FUSILEV ® 57 Fanapt ® 57 Novogyne 57 should consult NeurogesX 57 ZEGERID Capsules 57 Phase lll 57 Dendreon investigational 57 TM Acetavance TM 57 KRYSTEXXA TM 57 polysaccharide polymer 57 signal detection CTSD 57 EGRIFTA TM 57 Amitiza ® 57 rheumatoid arthritis thrombocytopenia 57 ATRA IV 56 Besivance 56 Increlex TM 56 markets HP Acthar 56 OTC ZEGERID 56 SYCREST 56 Janis Joplin soundalike respiratory 56 Kyowa Kirin 56 Captisol ® 56 VIAtab TM 56 TRANSDUR ® 56 FavId 56 payor acceptance 56 Veronate R 56 proprietary PharmacoSurgery ™ 56 ELADUR 56 sirtuin modulators 56 Personalized Immunotherapy 56 novel VDA molecule 56 GERD migraine headaches 56 Launches Generic Version 56 anti CD3 monoclonal 56 please visit www.cpexpharm.com 56 treat hyperproliferative disorders 56 Exelbine 56 Rexahn reliance 56 RELOVAIR ™ 56 proprietary intranasal insulin 56 TIMERx 56 TÎ ² 4 56 nasal calcitonin product 56 generic Copaxone 56 may diverge numerically 56 include Biosite Medarex 56 Sepracor anticipates 56 Visudyne R 56 Biological License Application 56 subsidiaries visit http:/www.apricusbio.com 56 pancreatic prostate 56 AcryMed technologies 56 Prochieve R 56 Tβ4 synthetic copy 56 conditional verb tenses 56 Sucampo Pharmaceuticals anticipates 56 CYT# vascular disrupting 56 ESTRASORB R 56 PLK1 SNALP 56 invoiced shipments 56 ocular formulation 56 molecular imaging radiopharmaceutical 56 TRANSDUR Sufentanil 56 Alfacell proprietary ribonuclease 56 Zeneus 56 Nektar proprietary 56 please visit www.advaxis.com 56 eptifibatide Injection 56 BRILINTA 56 Peyronie disease Frozen Shoulder 56 severe hypercholesterolemia 56 polymer conjugate technology 56 BHT DNA 56 ALN TTR# 56 sapropterin dihydrochloride Phase 56 mecamylamine hydrochloride 56 Avivo Corporation 56 Myriad logo BRACAnalysis 56 Cumulase 56 HERmark assay 56 Micromet proprietary BiTE 56 Budesonide foam crofelemer 56 potentially treat nephropathic 56 Panbio Limited 56 oxandrolone USP 56 P#X# antagonist 56 includes TOLAMBA TM 56 DWS Trust 56 markets Testim ® 56 NxStage anticipates 56 candidate Ramoplanin 56 candidate MyVax 56 CAMPATH 56 Bacterin proprietary 56 Recurring royalties 56 based pretargeting methods 56 TranSwitch filings 56 Enpath ability 56 microsurgical disciplines 56 Bilive 56 Aganocide 56 targeting Inflammatory Bowel 56 TRISENOX ® 56 Pegloticase 56 RAPTIVA 56 Topical Interferon Alpha 2b 56 interferon gamma 1b 56 DexaSite 56 Luveris R Ovidrel R 56 Sular formulation 56 Omrix biosurgery product 56 Cleviprex TM clevidipine 56 corticotropin injection 56 ALN HPN 56 Phase #b/#a trial 56 Vectibix panitumumab 56 MTHFD1L gene 56 humanized therapeutic 56 BiDil XR 56 TransVax tm 56 Sepracor patents 56 Zanaflex Capsules 56 MKC# MT 56 delivery polymer matrix 56 markets COLAZAL 56 Prednisporin TM 56 Boehringer Ingelheim MedImmune 56 TM Aganocide 56 budesonide foam 56 HP Acthar R 56 please visit http:/www.toshiba.com/taec/ 56 Announces Tentative Approval 56 Celgene Thalomid 56 Omigard 56 develop PS# 56 Ereska 56 AzaSite ISV 56 R rilonacept Injection 56 CYP#A# CYP#D# 56 anti psychotic Seroquel 56 Aphthasol R 56 excludes acquisitions divestitures 56 painkiller Valium 56 ABILIFY ® 56 doxercalciferol 56 Aeolus Pharmaceuticals Announces 56 Somatuline R Depot 56 HepeX B TM 56 Excluding acquisitions divestitures 56 SPRYCEL ® 56 drug figitumumab 56 HEPLISAV TM hepatitis B 56 hoFH 56 â € œwill â 56 THR beta agonist 56 Fludara ® 56 PLAVIX R 56 confirmatory pivotal 56 Publication Classified Ad 56 refractory chronic lymphocytic 56 website www.nyandcompany.com 56 IV RSD# 56 COPEGUS R 56 3Q FY# representing 56 migraine headaches neuropathic pain 56 Campto 55 novel trazodone formulation 55 CD# CEA 55 Bayer Yasmin 55 Mr. Cavala manages 55 PS# Pharmacopeia ability 55 SILENOR TM 55 highly purified pasteurized 55 MethyPatch 55 Milestone Payments 55 MCSP respectively 55 CLX Investments 55 offuture 55 RESTASIS 55 2 methoxyestradiol 55 HealthStream Learning 55 Wellbutrin XL R 55 hepatitis B immune globulin 55 intravenous acetaminophen 55 bovine thrombin 55 reflect Medicago 55 faropenem medoxomil 55 vaginal lidocaine 55 SumTotal logo 55 Panzem R 55 SinuNase TM 55 affecting Amarin 55 Metabasis dependence 55 Emtriva Viread 55 d l leucovorin 55 d Represents 55 PDP MLR 55 R lenalidomide 55 Staphylococcus aureus Immune Globulin 55 OSI Pharmaceuticals filings 55 tramadol ER 55 Achieves Primary Endpoint 55 TNFerade ™ 55 Excellarate TM 55 solid tumors ZYBRESTAT 55 unfavorable variances 55 basal cell carcinoma squamous 55 STRIANT 55 Ortho Cept 55 Completes Patient Enrollment 55 NEUPOGEN 55 Nascobal 55 ACAPODENE TM 55 Onalta ™ 55 Linebackers Kawika Mitchell 55 incorporate proprietary Microvolt 55 evaluating intravenous picoplatin 55 Actimmune R 55 Gabapentin GR TM 55 DepoCyt ® Abelcet ® 55 candidate AQ4N 55 operatingincome 55 panitumumab Vectibix 55 PORxin TM 55 SUPPRELIN LA DELATESTRYL 55 acquisitions mergers dispositions 55 novel histone deacetylase 55 Edwards Lifesciences AG 55 Kuvan TM sapropterin 55 SUPPRELIN LA 55 SNALP technology 55 DPX Survivac 55 recurrent metastatic ovarian cancer 55 shape zeta 55 MEDAREX 55 dimebon latrepirdine 55 Ethyol 55 Wellbutrin XL ® 55 Begins Dosing 55 PrevOnco ™ 55 ACADIA pipeline 55 obj obj = 55 developing oral talactoferrin 55 GLASSIA 55 reflect Ronn Motor 55 ZALBIN 55 Kerastick ® 55 Fibrillex TM 55 REG2 Regado 55 Zavesca r 55 LungAlert TM 55 topical agent Xantryl 55 INSPIRE Trial Phase III 55 Mircette R 55 NASDAQ AKRX niche 55 FACTIVE R gemifloxacin 55 BiDil XR drug 55 candidate SILENOR TM 55 arenot limited 55 Targretin capsules 55 Daytrana TM 55 carcinoid syndrome diabetes 55 Kronos TiO2 55 JOULFERON 55 proprietary capillary aerosolization 55 Taisho Pharmaceuticals 55 BUPHENYL R 55 ARCALYST R 55 Airvana anticipates 55 Amaryl R 55 website www.novavax.com 55 Infergen R 55 Levoleucovorin 55 Rotarix R 55 HEPLISAV TM 55 Teveten 55 IMiDs ® compound 55 var arrUrl = 55 Somatuline Depot 55 Frova ® 55 lender consents 55 Aloprim TM allopurinol sodium 55 ELADUR TM 55 Thelin tm 55 developed PokerPro automated 55 MGI PHARMA marketed 55 didanosine associated 55 antidepressants fluoxetine 55 iii Cubist 55 website http:/www.sinovac.com 55 using VIAdel TM 55 Paramount Classics Insurge Pictures 55 Lexiscan ® 55 PharMerica LTC Transaction 55 Fortical ® nasal calcitonin 55 palonosetron hydrochloride injection 55 reflect GuestLogix 55 Company Nasdaq RGDX 55 TKM PLK1 55 ONTAK 55 XL# XL# 55 BEMA ® 55 Orosi Mill project 55 Atheros Quarterly Report 55 Gonal f 55 ZapMedia applied 55 Ruined temples 55 viii insufficient 55 endometriosis ovarian cysts 55 VANTAS ® 55 lead molecular radiotherapeutic 55 zileuton CR 55 prescription brands RESTYLANE 55 Neulasta R 55 IMiDs ® 55 lavender headscarf 55 Allovectin 7 R 55 c Relates 55 Marketing Approval PMA 55 IoGen ™ 55 visit www.genmab.com 55 GVAX R 55 Xeloda ® 55 Oracea TM 55 Nascobal ® 55 involverisks 55 Archexin 55 Vidaza R 55 PMPS brand 55 Lipofen 55 anti botulism antibody 55 G#DT 55 midstage clinical 55 CORLUX CORT # 55 OnDose 55 unique PER.C6 ® 55 Zegerid OTC 55 Pruvel TM 55 ViaCord R 55 APC Targeting Technology 55 PRESEPT study 55 Entereg R 55 risks associatedwith 55 Corp. BVF CN 55 alpha interferons 55 LUNESTA ® 55 Aversion r Technology 55 INTEGRILIN 55 clinical trials SGN 55 anthracycline taxane 55 AZASITE 55 ARIKACE ™ 55 deforolimus 55 ClindaReach ® 55 please visit www.sucampo.com 55 UltiMAb 55 specialty injectables 55 Bioenvision filings 55 Including newbuildings 55 Grupo Simec Announces 55 RECOTHROM ® 55 risksand uncertainties 55 HuMax CD#b 55 vaccine GMK 55 PENTASA 55 Synerx 55 Dynegy cautions 55 var arrContent = 55 PROMACTA ® 55 glatiramer 55 evaluating satraplatin 55 research anddevelopment 55 historicalfacts 54 ASONEP TM 54 candidate XP# 54 GlycoPEGylated hemostasis compounds 54 Dyloject TM 54 adenosine injection 54 symbol AVXL 54 urocortin 2 54 XOMA 3AB biodefense 54 MAGE A3 ASCI 54 aresubject 54 HCV RNA polymerase 54 Urocidin TM 54 Enjuvia 54 Trofex 54 referenced investigational 54 Nitoman 54 Inc CRIS 54 ACTIQ 54 Klean Prep TM 54 Currency translation negatively impacted 54 Lexiscan R 54 apoptosis inducer 54 vaginally administered lidocaine 54 palonosetron hydrochloride Injection Dacogen 54 including priceline mortgage 54 PLAVIX R patent 54 include Healive 54 Zovirax R 54 Cardio Vascu Grow 54 Atrisorb D R 54 TRACON Pharmaceuticals 54 BioSante Pharmaceuticals Announces 54 Achillion anticipates 54 BioMarin Genzyme LLC 54 glucokinase activator 54 CRIXIVAN 54 Hugoton Properties 54 Fortical 54 prolific Slave Craton 54 M Enoxaparin 54 Quaker BioVentures invests 54 ABRAXANE TM 54 CIMZIA r 54 factor VIIa 54 coronary stent merged 54 GSK# [002] 54 Amgen Neulasta R 54 IV Infusion Therapy 54 ABILIFY R 54 Levulan ® PDT 54 MSCRAMM R 54 IV acetaminophen 54 testosterone buccal system 54 VYVANSE TM lisdexamfetamine 54 Leukine ® 54 generic Valtrex 54 miconazole Lauriad ® 54 ZYFLO 54 biotherapeutic drugs 54 HGS ETR1 mapatumumab 54 Saforis 54 metaglidasen 54 Receives Approvable Letter 54 UCB Keppra 54 Submits Supplemental 54 prioryear 54 ThermoDox ® clinical 54 bardoxolone 54 transgenically produced product 54 GLP toxicology studies 54 borrower depositor 54 SANCTURA R 54 GrowthWorks refers 54 novel orally inhaled 54 Q#IR 54 targeting abnormally proliferating 54 pyrexia mucositis sepsis febrile 54 proprietary PharmacoSurgery TM 54 InSite reliance 54 nausea dehydration dyspnea 54 next generation URAT1 54 properties ultimate recoverability 54 mesylate tablets approved 54 Visian Toric ICL 54 AbD segment 54 Nicotine Conjugate Vaccine 54 ENRICH trial 54 thousand BOEPD 54 Traci Arbios 54 PORxin TM platforms 54 tramiprosate Alzhemed TM 54 receiving XGEVA 54 Rescula 54 Taiho Pharmaceutical 54 anduncertainties 54 Illumigen Biosciences Inc. 54 GABITRIL 54 GRALISE 54 Azmacort R 54 proprietary BiTE ® 54 unforeseen underperformance 54 include Alferon N 54 TRANSDUR ™ 54 concerning Xanthus 54 phase III isavuconazole 54 contain Senomyx flavor 54 aldehyde dehydrogenase ALDH2 deficiency 54 Bioral Amphotericin B. 54 Orthovisc R 54 Abelcet 54 ZFNs clinical trials 54 visit http:/www.cytrx.com 54 withrespect 54 MyVax R 54 oral hypoglycemic agent 54 commercializing Loramyc ® 54 MediGene focuses 54 Biaxin XL 54 compound CIP FENOFIBRATE 54 couldcause actual results 54 NPS NPS Pharmaceuticals 54 Inc. NASDAQ EVVV 54 infectious diseases autoimmune diseases 54 Difimicin 54 HCD# [002] 54 ARCALYST ® 54 ALN VSP Phase 54 Alprox TD 54 boxer dachshund bulldog 54 chemokine receptor CCR1 54 CYT# potent vascular disrupting 54 ViroChem Pharma Inc. 54 Receives Milestone Payment 54 SILENOR TM doxepin HCl 54 POSIDUR TM 54 Mircette 54 AlgoRx 54 Laurion cautions against 54 LFRP 54 Gonal f R 54 ORENCIA R 54 QUADRAMET R 54 Entereg TM 54 Aganocide TM 54 Form 8K #K 54 ev3 peripheral vascular 54 involve risksand uncertainties 54 Zorbtive TM 54 involve risks anduncertainties 54 NPS complements 54 ularitide 54 VISICOL R 54 albiglutide 54 Elevess 54 limitedto 54 Stimuvax R 54 MVAS gross 54 Asentar 54 MOZOBIL 54 SearchHelp communications 54 therapeutic peptide 54 MassARRAY R 54 nonhematologic adverse reactions 54 verdict elicited gasps 54 ENTOCORT EC 54 Nipent R 54 XYREM 54 rxRNA 54 unique PER.C6 54 EDEMA3 54 Quicksilver Resources filings 54 pharmacogenomics pharmacogenetics 54 services visit www.networkengines.com 54 Gabon Cote d' 54 oxaliplatin Eloxatin 54 PDX pralatrexate 54 ParAllele 54 APNB believes 54 Iluvien ® 54 candidate NGX 54 Tyzeka Sebivo 54 fund BioSante LibiGel 54 Megace R ES 54 BioForce Nanosciences actual 54 enoxaparin sodium injection 54 ZANAFLEX CAPSULES 54 Clearant Process ® 54 Atridox R Atrisorb 54 Amlodipine Besylate Tablets 54 Franco Zeffirelli miniseries 54 erlotinib Tarceva R 54 Polyurethanes segment 54 www.pranabio.com 54 AspenTech periodic reports 54 AGGRASTAT R tirofiban hydrochloride 54 TFChem licenses 54 Amlodipine Besylate 54 diarrhea nausea abdominal pain 54 Receive Milestone Payment 54 evaluating tivozanib 54 regarding Anviron 54 Factor VIIa Factor VIII 54 Adjusted Timeshare 54 scalable PLX PLacental 54 treat refractory angina 54 Alnylam #x# 54 Pervasip actual 54 mg dL triglycerides 54 AVINZA ® 54 initiate multicenter 54 methylnaltrexone bromide 54 Egrifta 54 S1P antibody 54 Aphthasol ® 54 DARA logo 54 Zovirax ® 54 Shire Attention Deficit 54 treat dysmenorrhea 54 Variable Interest Entities VIEs 54 Hematide ™ 54 Inc NASDAQ CISG 54 Merck OSI Pharmaceuticals 54 telomerase therapeutic 54 topical dermatology 54 vinyl siding MORE 54 staphylococcal vaccine 54 Demonstrates Significant 54 sumatriptan injection 54 Tyzeka 54 difficulties foreseeing 54 Potelligent Technology 54 Vaxfectin TM 54 concerning Zalicus 54 Lilly ICOS joint venture 54 Agria beliefs 54 DYNACIN R Tablets 54 Biologic License Application BLA 54 rusalatide acetate 54 acyclovir Lauriad R 54 semi synthetic lipoglycopeptide 54 suchstatements 54 uncertaintiesthat 54 Selzentry Celsentri 54 punctal plug 54 RECOTHROM R 54 Vascular Wrap TM 54 ZANAFLEX CAPSULES ® tizanidine 54 LEVADEX orally inhaled 54 BiovaxID TM 54 trastuzumab DM1 T DM1 54 Drug eluting stent 54 AVINZA 54 Soriatane 54 Copegus R 54 HYVISC R 54 Loramyc TM 54 Plenaxis R 54 dermaceutical 54 quinapril 54 Nucleic Acid Detection Immunoassay 54 ruxolitinib 54 Generics Segment 54 Baqoubah north 54 brostallicin 54 infectious diseases autoimmune 54 Generx ™ 54 incorporate CXA 54 modified glutathione analog 54 lenalidomide Revlimid R 54 economically recoverable coal 54 GlaxoSmithKline Kyowa Kirin 54 glittering dupatta scarves 54 progressive metastatic prostate 54 Gestiva TM 54 Cetrotide R 54 oral hypoglycemic agents 54 initiate Phase IIa 54 clinical trials Archexin 54 ARLP Partnership 54 Xenazine ® 54 Tekamlo 54 Adoxa 54 CB2 selective receptor agonist